Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with graves' disease in Japanese

Thyroid

Volumn 16, Issue 5, 2006, Pages 443-446

  Ban, Yoshiyuki ^a   Tozaki, Teruaki ^b,c   Taniyama, Matsuo ^d   Tomita, Motowo ^b   Ban, Yoshio ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c LABORATORY OF RACING CHEMISTRY   (Japan)

^d SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD40 ANTIGEN; DNA; RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY;

5' UNTRANSLATED REGION; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 20Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE; GENE FREQUENCY; GENOTYPE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; JAPAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ALLELES; ANTIGENS, CD40; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; JAPAN; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROIDITIS, AUTOIMMUNE;

EID: 33745203966     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.443     Document Type: Article

References (21)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223-243.
2. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
3. Davies TF 2000 Graves' diseases: Pathogenesis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A fundamental and Clinical Text. Lippincott Williams & Wilkins, Philadelphia, pp. 518-530.
4. Tomer Y, Davies TF 2003 Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 24:694-717.
5. Tomer Y, Davies TF 1993 Infection, thyroid disease and autoimmunity. Endocr Rev 14:107-120.
6. Brix TH, Hansen PS, Kyvik KO , Hegedus L 2000 Cigarette smoking and risk of clinically overt thyroid disease: A population-based twin case-control study. Arch Intern Med 160:661-666.
7. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1998 A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 63:1749-1756.
8. Pearce SH, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P 1999 Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease [letter]. Am J Hum Genet 65:1462-1465.
9. Tomer Y, Concepcion E, Greenberg DA 2002 A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12:1129-1135.
10. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park DJ 2003 A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13:919-925.
11. Woolf B 1955 On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
12. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ 1994 The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15:406-411.
13. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S 1994 The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922.
14. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ 1996 Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591-617.
15. Carayanniotis G, Masters SR, Noelle RJ 1997 Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421-426.
16. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC 2004 A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin Endocrinol (Oxf) 61:269-272.
17. Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, Perros P, Pearce SH 2004 Role of the CD40 locus in Graves' disease. Thyroid 14:506-509.
18. Simmonds MJ, Heward JM, Franklyn JA, Gough SC 2005 The CD40 Kozak SNP: A new susceptibility loci for Graves' disease [letter]? Clin Endocrinol (Oxf) 63:232-233.
19. Tomer Y, Davies TF, Greenberg DA 2005 What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease [letter]? Clin Endocrinol (Oxf) 62:258.
20. Jacobson EM, Concepcion ES, Oashi T, Tomer Y 2005 A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: A case for translational pathophysiology. Endocrinology 146:2684-2691.
21. Taylor JC, Gough SC, Hunt PJ, Brix TH, Chatterjee K, Connell JM, Franklyn JA, Hegedus L, Robinson BG, Wiersinga WM, Wass JA, Zabaneh D, Mackay I, Weetman AP 2006 A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 91:646-653.